{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T23:22:33Z","timestamp":1787440953051,"version":"build-2736575974"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012001","name":"Al Jalila Foundation","doi-asserted-by":"publisher","award":["AJF2023\\u2013172"],"award-info":[{"award-number":["AJF2023\\u2013172"]}],"id":[{"id":"10.13039\/100012001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.biopha.2026.119591","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:13:40Z","timestamp":1780028020000},"page":"119591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Estrogen \/progesterone receptor-gasdermin E axis links hormone signalling to pyroptotic cell death, anti-tumour immunity and response to chemotherapy in breast cancer cells"],"prefix":"10.1016","volume":"200","author":[{"given":"Lama","family":"Lozon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafaa S.","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julika","family":"Ribbat-Idel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4511-6037","authenticated-orcid":false,"given":"Thorben","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Gemoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Perner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael Y.","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raafat","family":"El-Awady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119591_bib1","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.biopha.2026.119591_bib2","first-page":"135","article-title":"Estrogen receptor signaling mechanisms [Internet]","volume":"116","author":"Fuentes","year":"2019"},{"issue":"3","key":"10.1016\/j.biopha.2026.119591_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1586\/eem.11.25","article-title":"Progesterone receptor action: Defining a role in breast cancer","volume":"6","author":"Daniel","year":"2011","journal-title":"Expert Rev. Endocrinol. Metab."},{"issue":"44","key":"10.1016\/j.biopha.2026.119591_bib4","doi-asserted-by":"crossref","first-page":"18060","DOI":"10.1073\/pnas.1018858109","article-title":"Estrogen receptor prevents p53-dependent apoptosis in breast cancer","volume":"109","author":"Bailey","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"34","key":"10.1016\/j.biopha.2026.119591_bib5","doi-asserted-by":"crossref","first-page":"15081","DOI":"10.1073\/pnas.1009575107","article-title":"Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation","volume":"107","author":"Konduri","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.biopha.2026.119591_bib6","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41591-019-0432-4","article-title":"Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial","volume":"25","author":"Voorwerk","year":"2019","journal-title":"Nat. Med [Internet]"},{"issue":"1","key":"10.1016\/j.biopha.2026.119591_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41523-023-00543-0","article-title":"Immune landscape of breast tumors with low and intermediate estrogen receptor expression","volume":"9","author":"Voorwerk","year":"2023","journal-title":"npj Breast Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119591_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-023-00508-3","article-title":"Immunotherapy in breast cancer: an overview of current strategies and perspectives","volume":"9","author":"Debien","year":"2023","journal-title":"npj Breast Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2026.119591_bib9","article-title":"Cell death pathways: intricate connections and disease implications","volume":"40","author":"Kist","year":"2021","journal-title":"EMBO J. [Internet]"},{"issue":"13","key":"10.1016\/j.biopha.2026.119591_bib10","doi-asserted-by":"crossref","first-page":"R568","DOI":"10.1016\/j.cub.2016.02.019","article-title":"Pyroptosis","volume":"26","author":"Vande Walle","year":"2016","journal-title":"Curr. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119591_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41577-019-0228-2","article-title":"The gasdermins, a protein family executing cell death and inflammation","volume":"20","author":"Broz","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"7799","key":"10.1016\/j.biopha.2026.119591_bib12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41586-020-2071-9","article-title":"Gasdermin E suppresses tumour growth by activating anti-tumour immunity","volume":"579","author":"Zhang","year":"2020","journal-title":"Nat. [Internet]"},{"issue":"2","key":"10.1016\/j.biopha.2026.119591_bib13","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ijrobp.2022.07.1841","article-title":"Ionizing Radiation Triggers the Antitumor Immunity by Inducing Gasdermin E-Mediated Pyroptosis in Tumor Cells","volume":"115","author":"Cao","year":"2023","journal-title":"Int J. Radiat. Oncol. [Internet]"},{"issue":"6","key":"10.1016\/j.biopha.2026.119591_bib14","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s11427-017-9158-x","article-title":"Chemotherapy drugs induce pyroptosis through caspase-3-dependent cleavage of GSDME","volume":"61","author":"Zhang","year":"2018","journal-title":"Sci. China Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119591_bib15","first-page":"1","article-title":"Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation","volume":"10","author":"Rogers","year":"2019","journal-title":"Nat. Commun. [Internet]"},{"issue":"7661","key":"10.1016\/j.biopha.2026.119591_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature22393","article-title":"Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin","volume":"547","author":"Wang","year":"2017","journal-title":"Nat. [Internet]"},{"issue":"1","key":"10.1016\/j.biopha.2026.119591_bib17","article-title":"Oncolytic Parapoxvirus induces Gasdermin E-mediated pyroptosis and activates antitumor immunity","volume":"14","author":"Lin","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2026.119591_bib18","first-page":"1","article-title":"Inhibition of CDC20 potentiates anti-tumor immunity through facilitating GSDME-mediated pyroptosis in prostate cancer","volume":"12","author":"Wu","year":"2023","journal-title":"Exp. Hematol. Oncol. [Internet]"},{"issue":"12","key":"10.1016\/j.biopha.2026.119591_bib19","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1002\/ijc.33390","article-title":"GSDME and its role in cancer: From behind the scenes to the front of the stage","volume":"148","author":"De Schutter","year":"2021","journal-title":"Int J. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119591_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-018-0479-y","article-title":"Large-scale analysis of DFNA5 methylation reveals its potential as biomarker for breast cancer","volume":"10","author":"Croes","year":"2018","journal-title":"Clin. Epigenetics"},{"issue":"5","key":"10.1016\/j.biopha.2026.119591_bib21","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/cam4.2103","article-title":"Methylation analysis of Gasdermin E shows great promise as a biomarker for colorectal cancer","volume":"8","author":"Ibrahim","year":"2019","journal-title":"Cancer Med"},{"issue":"8","key":"10.1016\/j.biopha.2026.119591_bib22","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s10038-006-0004-6","article-title":"The potential role of DFNA5, a hearing impairment gene, in p53-mediated cellular response to DNA damage","volume":"51","author":"Masuda","year":"2006","journal-title":"J. Hum. Genet"},{"issue":"17","key":"10.1016\/j.biopha.2026.119591_bib23","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.7150\/jca.48989","article-title":"Gasdermin E-mediated programmed cell death: An unpaved path to tumor suppression","volume":"12","author":"Wang","year":"2021","journal-title":"J. Cancer"},{"issue":"August","key":"10.1016\/j.biopha.2026.119591_bib24","first-page":"1","article-title":"p53\u2013GSDME Elevation: A Path for CDK7 Inhibition to Suppress Breast Cancer Cell Survival","volume":"8","author":"Wang","year":"2021","journal-title":"Front Mol. Biosci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119591_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-024-06455-6","article-title":"Transcription factor Sp1 transcriptionally enhances GSDME expression for pyroptosis","volume":"15","author":"Pan","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.biopha.2026.119591_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1432-1327.1998.2520169.x","article-title":"Characterization of a gene that is inversely correlated with estrogen receptor expression (ICERE-1) in breast carcinomas","volume":"252","author":"Thompson","year":"1998","journal-title":"Eur. J. Biochem"},{"issue":"3","key":"10.1016\/j.biopha.2026.119591_bib27","first-page":"1","article-title":"GOBO: Gene Expression-Based Outcome for Breast Cancer Online","volume":"6","author":"Ringn\u00e9r","year":"2011","journal-title":"PLoS One [Internet]"},{"issue":"6","key":"10.1016\/j.biopha.2026.119591_bib28","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat. Biotechnol. [Internet]"},{"issue":"December 2020","key":"10.1016\/j.biopha.2026.119591_bib29","article-title":"Tangeretin boosts the anticancer activity of metformin in breast cancer cells via curbing the energy production","volume":"83","author":"Mdkhana","year":"2021","journal-title":"Phytomedicine"},{"issue":"December 2020","key":"10.1016\/j.biopha.2026.119591_bib30","article-title":"Nuclear factor-\u03baB signaling inhibitors revert multidrug-resistance in breast cancer cells","volume":"340","author":"Abdin","year":"2021","journal-title":"Chem. Biol. Inter. [Internet"},{"issue":"17","key":"10.1016\/j.biopha.2026.119591_bib31","doi-asserted-by":"crossref","first-page":"8159","DOI":"10.1111\/jcmm.16574","article-title":"Caspase-3-mediated GSDME induced Pyroptosis in breast cancer cells through the ROS\/JNK signalling pathway","volume":"25","author":"Zhang","year":"2021","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.biopha.2026.119591_bib32","doi-asserted-by":"crossref","unstructured":"Lozon L., Saleh E., Menon V., Ramadan W., Amin A. Effect of Safranal On The Response Of Cancer Cells To Topoisomerase I Inhibitors: Dose Sequence. 2022.","DOI":"10.21203\/rs.3.rs-1199263\/v1"},{"issue":"October","key":"10.1016\/j.biopha.2026.119591_bib33","first-page":"1","article-title":"Spatial Distribution of Immune Cells in Head and Neck Squamous Cell Carcinomas","volume":"11","author":"Idel","year":"2021","journal-title":"Front Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119591_bib34","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep. [Internet]"},{"key":"10.1016\/j.biopha.2026.119591_bib35","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4103\/jdmimsu.jdmimsu_7_20","article-title":"Comparison of various scoring systems by immunohistochemistry for evaluating hormone receptors (Estrogen receptor and progesterone receptor) in carcinoma of breast","volume":"15","author":"Rai","year":"2020","journal-title":"J. Datta Meghe Inst. Med Sci. Univ."},{"issue":"8","key":"10.1016\/j.biopha.2026.119591_bib36","first-page":"716","article-title":"Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol &amp","volume":"109","author":"McCarty","year":"1985","journal-title":"Lab Med [Internet]"},{"key":"10.1016\/j.biopha.2026.119591_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dnarep.2015.10.004","article-title":"Modulation of DNA damage response and induction of apoptosis mediates synergism between doxorubicin and a new imidazopyridine derivative in breast and lung cancer cells","volume":"37","author":"El-Awady","year":"2016","journal-title":"DNA Repair (Amst. )"},{"issue":"12","key":"10.1016\/j.biopha.2026.119591_bib38","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s41592-020-00998-0","article-title":"diaPASEF: parallel accumulation\u2013serial fragmentation combined with data-independent acquisition","volume":"17","author":"Meier","year":"2020","journal-title":"Nat. Methods [Internet]"},{"issue":"1","key":"10.1016\/j.biopha.2026.119591_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","article-title":"DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput","volume":"17","author":"Demichev","year":"2020","journal-title":"Nat. Methods [Internet]"},{"issue":"1","key":"10.1016\/j.biopha.2026.119591_bib40","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1038\/s41467-022-31492-0","article-title":"dia-PASEF data analysis using FragPipe and DIA-NN for deep proteomics of low sample amounts","volume":"13","author":"Demichev","year":"2022","journal-title":"Nat. Commun. [Internet]"},{"issue":"1","key":"10.1016\/j.biopha.2026.119591_bib41","first-page":"1","article-title":"Proteomic analyses identify HK1 and ATP5A to be overexpressed in distant metastases of lung adenocarcinomas compared to matched primary tumors","volume":"13","author":"Pasternack","year":"2023","journal-title":"Sci. Rep. [Internet]"},{"issue":"3","key":"10.1016\/j.biopha.2026.119591_bib42","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat. Genet [Internet]"},{"issue":"43","key":"10.1016\/j.biopha.2026.119591_bib43","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. [Internet]"},{"issue":"1","key":"10.1016\/j.biopha.2026.119591_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clon.2015.10.005","article-title":"Understanding Oestrogen Receptor Function in Breast Cancer and its Interaction with the Progesterone Receptor. New Preclinical Findings and their Clinical Implications","volume":"28","author":"Baird","year":"2016","journal-title":"Clin. Oncol. [Internet]"},{"issue":"1","key":"10.1016\/j.biopha.2026.119591_bib45","article-title":"Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy","volume":"6","author":"Kang","year":"2021","journal-title":"Signal Transduct. Target Ther. [Internet]"},{"key":"10.1016\/j.biopha.2026.119591_bib46","doi-asserted-by":"crossref","unstructured":"Liu H., Ma J., Fang X., Tang D. Expression of RPL32 predicts response to anthracycline-based neoadjuvant chemotherapy in triple-negative breast cancer [Internet]. Research Square; 2022. Available from: https:\/\/doi.org\/10.21203\/rs.3.rs-1539834\/v1.","DOI":"10.21203\/rs.3.rs-1539834\/v1"},{"issue":"4","key":"10.1016\/j.biopha.2026.119591_bib47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrg3185","article-title":"Insights into the regulation of protein abundance from proteomic and transcriptomic analyses","volume":"13","author":"Vogel","year":"2012","journal-title":"Nat. Rev. Genet [Internet]"},{"key":"10.1016\/j.biopha.2026.119591_bib48","first-page":"2","article-title":"Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action","volume":"90","author":"Osborne","year":"2004"},{"key":"10.1016\/j.biopha.2026.119591_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.12.012","article-title":"Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment","volume":"186","author":"Patel","year":"2018","journal-title":"Pharm. Ther. [Internet]"},{"issue":"7560","key":"10.1016\/j.biopha.2026.119591_bib50","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature14583","article-title":"Progesterone receptor modulates ER\u03b1 action in breast cancer","volume":"523","author":"Mohammed","year":"2015","journal-title":"Nature"},{"issue":"September","key":"10.1016\/j.biopha.2026.119591_bib51","first-page":"1","article-title":"Upregulation of an estrogen receptor-regulated gene by first generation progestins requires both the progesterone receptor and estrogen receptor alpha","volume":"13","author":"Perkins","year":"2022","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.biopha.2026.119591_bib52","first-page":"1","article-title":"Promoting GSDME expression through DNA demethylation to increase chemosensitivity of breast cancer MCF-7 \/ Taxol cells","volume":"18","author":"Id","year":"2023"},{"key":"10.1016\/j.biopha.2026.119591_bib53","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ebiom.2019.02.012","article-title":"A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma","volume":"41","author":"Wu","year":"2019","journal-title":"EBioMedicine [Internet]"},{"issue":"6417","key":"10.1016\/j.biopha.2026.119591_bib54","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.aar7607","article-title":"ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation","volume":"362","author":"R\u00fchl","year":"2018","journal-title":"Science (80-)"},{"issue":"6","key":"10.1016\/j.biopha.2026.119591_bib55","first-page":"576","article-title":"Reversal effect of mifepristone on adriamycin resistance in human breast cancer cell line MCF-7\/ADM in vitro and in vivo","volume":"35","author":"Huang","year":"2010","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban."},{"issue":"13","key":"10.1016\/j.biopha.2026.119591_bib56","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/cncr.32057","article-title":"Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor\u2013positive, human epidermal growth factor receptor 2\u2013negative breast cancer (CBCSG-036): A randomized, controlled, multicenter trial","volume":"125","author":"Yu","year":"2019","journal-title":"Cancer"},{"issue":"February","key":"10.1016\/j.biopha.2026.119591_bib57","article-title":"Neoadjuvant chemotherapy in hormone receptor-positive\/HER2-negative early breast cancer: When, why and what?","volume":"160","author":"Torrisi","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol. [Internet"},{"issue":"5","key":"10.1016\/j.biopha.2026.119591_bib58","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1158\/0008-5472.CAN-20-1441","article-title":"Enhanced antitumor immunity via endocrine therapy prevents mammary tumor relapse and increases immune checkpoint blockade sensitivity","volume":"81","author":"Sequeira","year":"2021","journal-title":"Cancer Res"},{"issue":"20","key":"10.1016\/j.biopha.2026.119591_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015048","article-title":"Hormone Receptor Signaling and Breast Cancer Resistance to Anti-Tumor Immunity","volume":"24","author":"Moisand","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119591_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: The cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.biopha.2026.119591_bib61","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/s41556-022-00857-4","article-title":"Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1\u2013mucin pathway","volume":"24","author":"Lv","year":"2022","journal-title":"Nat. Cell Biol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119591_bib62","doi-asserted-by":"crossref","first-page":"8049","DOI":"10.1021\/acs.nanolett.9b03245","article-title":"Epigenetics-Based Tumor Cells Pyroptosis for Enhancing the Immunological Effect of Chemotherapeutic Nanocarriers","volume":"19","author":"Fan","year":"2019","journal-title":"Nano Lett. [Internet]"},{"key":"10.1016\/j.biopha.2026.119591_bib63","first-page":"1","article-title":"Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic\/pyroptotic cell death","volume":"8","author":"Rogers","year":"2017","journal-title":"Nat. Commun. [Internet]"},{"issue":"1","key":"10.1016\/j.biopha.2026.119591_bib64","article-title":"The caspase-3\/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer","volume":"6","author":"Jiang","year":"2020","journal-title":"Cell Death Discov. [Internet]"},{"issue":"1","key":"10.1016\/j.biopha.2026.119591_bib65","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4049\/jimmunol.2100963","article-title":"Identification of RPL15 60S Ribosomal Protein as a Novel Topotecan Target Protein That Correlates with DAMP Secretion and Antitumor Immune Activation","volume":"209","author":"Yamada","year":"2022","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119591_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BSR20211577","article-title":"Deregulation of ribosomal proteins in human cancers","volume":"41","author":"El Khoury","year":"2021","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119591_bib67","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40425-019-0556-6","article-title":"Collagen density regulates the activity of tumor-infiltrating T cells","volume":"7","author":"Kuczek","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2026.119591_bib68","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2119463119","article-title":"Carcinomas assemble a filamentous CXCL12-keratin-19 coating that suppresses T cell-mediated immune attack","volume":"119","author":"Wang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.biopha.2026.119591_bib69","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/cyto.a.22302","article-title":"Human NK cell receptors\/markers: A tool to analyze NK cell development, subsets and function","volume":"83","author":"Montaldo","year":"2013","journal-title":"Cytom. Part A"},{"key":"10.1016\/j.biopha.2026.119591_bib70","article-title":"DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy","volume":"14","author":"Cifaldi","year":"2023","journal-title":"Front Immunol. [Internet]"},{"issue":"10","key":"10.1016\/j.biopha.2026.119591_bib71","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1629780","article-title":"Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome","volume":"8","author":"Noblejas-L\u00f3pez","year":"2019","journal-title":"Oncoimmunology"},{"issue":"16\\_","key":"10.1016\/j.biopha.2026.119591_bib72","article-title":"Effect of doxorubicin on efficacy of immune checkpoint inhibitors through increasing infiltration of CD8-positive T cells and activating STAT1-IRF1-CXCL10 axis","volume":"41","author":"Xiaosu","year":"2023","journal-title":"J. Clin. Oncol. [Internet]"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222600627X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222600627X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:57:26Z","timestamp":1787439446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222600627X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":72,"alternative-id":["S075333222600627X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119591","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estrogen \/progesterone receptor-gasdermin E axis links hormone signalling to pyroptotic cell death, anti-tumour immunity and response to chemotherapy in breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119591","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119591"}}